Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

Starting soon

Conditions studied: B Chronic Lymphocytic Leukemia

In brief

Reticulocyte parameters as early indicators of bone marrow erythropoietic activity in chronic B lymphoproliferative neoplasms

Key facts

Study ID

NCT07337967

Run by

Huda Ahmed Abdelsabour Abdelwahab

People needed

120

Starts

2026-01-01

Expected to finish

2027-09-01

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Newly diagnosed adult patients with Chronic B LymphoPoliferative neoplasm according to WHO classification.

You may not qualify if…

• Patients received chemotherapy.
• Patients with Active bleeding
• Patients with recent blood transfusion (less than 2 weeks).
• Patients on haematinics or vitamin B 12 therapy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.